HHS could ban COVID-19 shot within months, says MAHA insider

The Department of Health and Human Services (HHS) could pull the COVID-19 mRNA shots off the market soon, according to a MAHA insider.

According to The Daily Beast, cardiologist Dr. Aseem Malhotra has revealed that the injections are likely to be banned in a matter of months, either in stages or all at once. Dr. Malhotra has been calling for the shots to be pulled off the market since 2022, after his father’s sudden death following the injections. The London-based physician is a top adviser to the lobby group Make America Healthy Again (MAHA) Action and reportedly has the ear of HHS Secretary Robert F. Kennedy, Jr. 

“It could [happen] in a number of stages, including learning more about the data,” said Malhotra. “But given the increased talk of vaccine injuries in the past few weeks among the administration, it could also come with one clean decision.”

The physician also said that many in Kennedy’s circle “cannot understand” why the shots, given their low efficacy and weak safety profile, are still authorized by the Food and Drug Administration (FDA). As of February 28, 2025, the CDC’s Vaccine Adverse Events Reporting System (VAERS) reported 38,476 deaths and millions of adverse events linked to the COVID shots in the U.S. alone. The CDC uses VAERS to track vaccine safety signals, and it has been aware for at least a decade that VAERS data are underreported by a factor of 20.

Malhotra said he expects to meet with President Trump next month to discuss pulling the mRNA vaccine off the market. The vaccine was developed under Trump’s Operation Warp Speed in 2020, which the president previously referred to as a “monumental achievement.”

“I think [Trump will] get it, because it’s in his interest to,” Malhotra said. “This information is only going in one direction, and there’s something really terribly wrong with the system. I think once [he] understands the situation… that will encourage him to act to change the system. He’s in a position to fix it. He can create a lasting legacy by doing so.”

Already pulling back on mRNA vaccine development

Kennedy announced earlier this month that HHS is terminating 22 contracts for mRNA vaccine development, collectively worth about $500 million.

“Most of these shots are for flu or COVID. But as the pandemic showed us, mRNA vaccines don’t perform well against viruses that infect the upper respiratory tract,” Kennedy said in a video posted to social media, explaining that mRNA shots cause “antigenic shift.”

“Here’s the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation, and the vaccine becomes ineffective,” he stated. “This dynamic drives a phenomenon called antigenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine.”

The health secretary said the decision came after “reviewing the science” and consulting with “top experts” at the National Institutes of Health (NIH) and Federal Drug Administration (FDA).

“To replace the troubled mRNA programs, we’re prioritizing the development of safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don’t collapse when viruses mutate,” he added.